Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
High 1.16 at 4:30 am ET, low 1.09 at 1:45 pm ET.
Inovio Pharmaceuticals, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“All revenue was derived under the collaborative arrangement with ApolloBio for the years ended December 31, 2025 and 2024 .”
$65,343 relationship
basisINO fy2025 · closed 2025-12 $65,343
FILING10-K0001055726-26-000008cik 0001055726
“Under the terms of the supply agreement, Coherus will provide LOQTORZI for a planned Phase 3 clinical trial.”
FILING10-K0001055726-26-000008cik 0001055726
“In addition, we previously relied on VGXI to manufacture DNA plasmids for our DNA medicine candidates before they became unable to produce the necessary plasmids due to a lack of manufacturing capacity.”
FILING10-K0001055726-26-000008cik 0001055726
“We have entered into agreements with government agencies, such as the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID), Defense Advanced Research Projects Agency (DARPA), Medical CBRN Defense Consortium (MCDC) and the Department of Defense (DoD) Joint Program Executive Office (JPEO) for Chemical, Biological, Radiological and Nuclear Defense (CBRN), and we intend to continue entering into these types of agreements with government agencies in the future.”
FILING10-K0001055726-26-000008cik 0001055726
“We have entered into agreements with government agencies, such as the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID), Defense Advanced Research Projects Agency (DARPA), Medical CBRN Defense Consortium (MCDC) and the Department of Defense (DoD) Joint Program Executive Office (JPEO) for Chemical, Biological, Radiological and Nuclear Defense (CBRN), and we intend to continue entering into these types of agreements with government agencies in the future.”
FILING10-K0001055726-26-000008cik 0001055726
“We have entered into agreements with government agencies, such as the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID), Defense Advanced Research Projects Agency (DARPA), Medical CBRN Defense Consortium (MCDC) and the Department of Defense (DoD) Joint Program Executive Office (JPEO) for Chemical, Biological, Radiological and Nuclear Defense (CBRN), and we intend to continue entering into these types of agreements with government agencies in the future.”
FILING10-K0001055726-26-000008cik 0001055726
“We have entered into agreements with government agencies, such as the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID), Defense Advanced Research Projects Agency (DARPA), Medical CBRN Defense Consortium (MCDC) and the Department of Defense (DoD) Joint Program Executive Office (JPEO) for Chemical, Biological, Radiological and Nuclear Defense (CBRN), and we intend to continue entering into these types of agreements with government agencies in the future.”
FILING10-K0001055726-26-000008cik 0001055726
Watchlist prices, news filtered to it, and its next report on your desk.
INO (Inovio Pharmaceuticals, Inc.) has 2 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
Inovio Pharmaceuticals, Inc. has 2 disclosed suppliers and 5 disclosed customers, each named in an SEC filing with the sentence that discloses it.